SomaLogic Board of Directors Kevin Conroy

Kevin Conroy

Chief Executive Officer of Exact Sciences Corporation

Kevin Conroy is Chairman and Chief Executive Officer of Exact Sciences Corporation (Nasdaq: EXAS), a molecular diagnostics company, which he joined in 2009. Before joining Exact Sciences Corporation, Mr. Conroy served as President and Chief Executive Officer of Third Wave Technologies, a molecular diagnostics company, from 2005 until the company’s acquisition by Hologic, Inc. in 2008. From 2004 to 2005, Mr. Conroy served as Third Wave’s General Counsel. Mr. Conroy also previously held leadership positions at GE Healthcare, a global leader in medical imaging and information technology. Mr. Conroy serves as a director of Epizyme, Inc. (Nasdaq: EPZM) and Adaptive Biotechnology Corporation (Nasdaq: ADPT), and previously served as director of ARYA Sciences Acquisition Corporation.

Mr. Conroy holds a J.D. from Michigan Law School and a B.A. in electrical engineering from Michigan State University.